Related Experiment Video
Updated: Feb 23, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Transcription factor Yin Yang 2 is a novel regulator of the p53/p21 axis
Vivi Kasim1,2, Yu-Dan Xie1, Hui-Min Wang1
1The Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.
Abstract:
Yin Yang 2 (YY2) is a multifunctional zinc-finger transcription factor that belongs to YY family. Unlike the well-characterized YY1, our understanding regarding the biological functions of YY2 is still very limited. Here we found for the first time that in contrast to YY1, which had been reported to be oncogenic, the expression level of YY2 in tumor cells and/or tissues was downregulated compared with its expression level in the normal ones. We also demonstrated that YY2 exerts biological function contrary to YY1 in cell proliferation. We elucidated that YY2 positively enhances p21 expression, and concomitantly, its silencing promotes cells to enter G2/M phase and enhances cell proliferation. Furthermore, we found that YY2 regulation on p21 occurs p53-dependently. Finally, we identified a novel YY2 binding site in the promoter region of tumor suppressor p53. We found that YY2 binds to the p53 promoter and activates its transcriptional activity, and subsequently, regulates cell cycle progression via p53/p21 axis. Taken together, our study not only identifies YY2 as a novel tumor suppressor gene that plays a pivotal role in cell cycle regulation, but also provides new insights regarding the regulatory mechanism of the conventional p53/p21 axis.
Insights
Yin Yang 2 (YY2) acts as a tumor suppressor by downregulating cell proliferation. This transcription factor enhances p53 and p21 expression, inhibiting cell cycle progression in cancer cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Yin Yang 2 (YY2) is a transcription factor with limited known functions, unlike its counterpart YY1.
- YY1 is known to be oncogenic, but YY2's role in cancer is largely unexplored.
Purpose of the Study:
- To investigate the role of YY2 in cancer and cell proliferation.
- To elucidate the molecular mechanisms underlying YY2's function in cell cycle regulation.
Main Methods:
- Analysis of YY2 expression levels in tumor versus normal tissues.
- Cell proliferation assays and cell cycle analysis upon YY2 manipulation.
- Western blotting and chromatin immunoprecipitation to assess protein interactions and transcriptional activity.
Main Results:
- YY2 expression is downregulated in tumor cells compared to normal cells.
- YY2 overexpression inhibits cell proliferation, while YY2 silencing promotes it.
- YY2 positively regulates p21 expression in a p53-dependent manner.
- YY2 binds to the p53 promoter, activating its transcription and subsequently regulating the p53/p21 axis.
Conclusions:
- YY2 functions as a tumor suppressor gene, inhibiting cell proliferation by regulating the p53/p21 pathway.
- This study reveals a novel mechanism for cell cycle control involving YY2 and the p53/p21 axis.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
03:37Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Master Transcription Regulators
Master Transcription Regulators
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle